Europital

A new article "Clinical Development in Challenging Cancers: Adrenocortical Carcinoma" written by our experts at Europital, has been published at the Journal for Clinical Studies. Our Medics took a closer look at Adrenocortical carcinoma, treatment of this rare type of cancer and future prospects based on Immunotherapy. We invite you all to read the complete publication: https://lnkd.in/gnwjm59

Clinical Development in Challenging Cancers: Adrenocortical Carcinoma - Journal for Clinical Studies Adrenocortical carcinoma (ACC) is a rare cancer with an estimated incidence of 1 to 2 patients per million people annually. About 50%–70% of adrenal cancers are functional; others instead have a more silent clinical presentation and are detected only when they grow to dimensions large enough to prod...

With the constantly increasing demand for our unique, high quality medical services, our team is continuously growing.
We welcomed recently 4 new members to our team: Ana, Evan, Lorelle and Tamara who will be an additional driving force into our team towards providing our current and future clients with our distinguished services and creative solutions.

Walking just 30 minutes three times per week could improve the quality of life for those with advanced cancer?

Interesting article found at the Medical Xpress - Medical and Health News



https://medicalxpress.com/news/2017-02-quality-life-patients-advanced-cancer.html

Quality of life for patients with advanced cancer improved through walking Walking for just 30 minutes three times per week could improve the quality of life for those with advanced cancer, a new study published in the BMJ Open journal has found.

An interesting article about Type 1 written by Ana Sandoiu at Medical News Today

http://www.medicalnewstoday.com/articles/315735.php?utm_content=buffer079d3&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

Our experts also shared their knowledge in the area, this time in regards to type 2 . Find out more here:
http://bit.ly/diabodyofproof

Body of Proof Obesity Management and Prognosis of Type 2 Diabetes: A view on Global standards http://www.samedanltd.com/magazine/current/11 Co-author: Dr Vijayanand

Our team is getting ready for the upcoming DIA Euromeeting conference, 29-31 of March in . Will you be there? Meet us at booth D8! DrugInfoAssn

http://www.diaglobal.org/en/flagship/euromeeting/about/conference

DIA EuroMeeting - About EuroMeeting 2017 About EuroMeeting 2017

February 4th is
Let's make a difference in the global fight against
Join the force and Spread the Word!
http://ow.ly/mAiW308zp1H

We are glad to officially announce our participation in the upcoming DIA Euromeeting conference taking place next 29 - 31 March in Glasgow DrugInfoAssn

Come over and visit our team at booth number D8!

http://www.diaglobal.org/en

Drug Information Association

Good Morning and wishing you all a good week ahead!

What if we tell you that it is possible to save time, energy and resources while providing study guidance in a Clinical Research Project by simpy using a multidecive platform?

Saving time, energy and resources while providing study guidance in Clinical Research Projects

The final feature of the Medical Management Series written by our experts at Europital, has been recently published at the Journal for Clinical Studies. In this article, the various medical activities during the close-out phase of a clinical study are discussed.

Did you already had the chance to read it? Don't miss it! Find the complete article at:

https://issuu.com/mark123/docs/51_jcs_november2016_web_85c846594eab81/24

JCS - Volume 8 Issue 6 - Nov 2016

The first documented case of multiple sclerosis was in 1421.More about the history of the disease at the following link:

Light bulb moments in multiple sclerosis A journey of discovery and diagnosis; looking back at the history of multiple sclerosis

Happy New Year from Europital Team! Wishing 2017 brings you all great success and looking forward to keep working as hard as in the previous year!